Yahoo Web Search

Search results

1. • Nektar Therapeutics (NASDAQ:NKTR) Given Consensus Recommendation of “Hold” by Analysts

     ETF DAILY NEWS· 6 days ago

     Nektar Therapeutics (NASDAQ:NKTR – Get Free Report) has received an average recommendation of “Hold” from the five ratings firms that are covering the stock, Marketbeat reports. Jefferies Financial ...

2. • AbbVie (NYSE:ABBV) Now Covered by Cantor Fitzgerald

     ETF DAILY NEWS· 6 days ago

     Cantor Fitzgerald assumed coverage on shares of AbbVie (NYSE:ABBV – Get Free Report) in a research note issued to investors on Friday, MarketBeat.com reports. Cantor Fitzgerald’s price objective ...

3. • 

     Dermata Therapeutics announces warrant exercise and new issuance By Investing.com

     Investing.com· 7 days ago

     Dermata Therapeutics, Inc. (NASDAQ:DRMA), a biotech firm engaged in skin disease treatments, has...

4. • 5 proposals for extracting water from the sea and air

     Hardwood Paroxysm· 6 days ago

     The sea can be an inexhaustible source of water, and several initiatives have already begun to take advantage of it for everyday uses, giving it the necessary treatments and ...

5. • Mizuho Boosts Arcutis Biotherapeutics (NASDAQ:ARQT) Price Target to $18.00

     ETF DAILY NEWS· 6 days ago

     Arcutis Biotherapeutics (NASDAQ:ARQT – Free Report) had its price target lifted by Mizuho from $17.00 to $18.00 in a report issued on Wednesday, Benzinga reports. They currently have a buy rating ...

6. • 

     7 Biotech Stocks That Could Breathe New Life Into Your Portfolio

     InvestorPlace· 4 days ago

     Fundamentally, one of the biggest advantages of biotech stocks to buy centers on the underlying...

7. • 

     Stress can be "the triggering factor" for skin problems. Dermatologists share their advice. - WDEF

     WDEF Chattanooga· 3 days ago

     Dermatologist Dr. Afton Cobb says she sees patients all the time who notice “the triggering factor...

8. • Jonathan Zalevsky Sells 7,355 Shares of Nektar Therapeutics (NASDAQ:NKTR) Stock

     ETF DAILY NEWS· 2 days ago

     Nektar Therapeutics (NASDAQ:NKTR – Get Free Report) insider Jonathan Zalevsky sold 7,355 shares of the stock in a transaction that occurred on Friday, May 17th. The shares were sold at an average ...

9. • Are Saunas Good for Your Skin? Discover How Women Over 50 Can Sweat Their Way to a More Radiant,...

     Fort Worth Star-Telegram· 3 days ago

     Relax and rejuvenate in no time!

10. • MoonLake Immunotherapeutics (NASDAQ:MLTX) Stock Rating Reaffirmed by HC Wainwright

      ETF DAILY NEWS· 5 days ago

      MoonLake Immunotherapeutics (NASDAQ:MLTX – Get Free Report)‘s stock had its “buy” rating reissued by equities researchers at HC Wainwright in a report released on Friday, Benzinga reports. HC ...